<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150223021208N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-11-20</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the effect of transcranial direct current stimulation (tDCS) with cognitive rehabilitation in autism</public_title>
      <acronym>transcranial direct current stimulation (tDCS); autism spectrum disorder (ASD)</acronym>
      <scientific_title>Comparing the effect of transcranial direct current stimulation (tDCS) with and without cognitive rehabilitation based on computerized task and occupational performance on executive functions in children with autism spectrum disorder aged 8-14 years</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-12-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52247</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Factorial, Purpose: Supportive, Blinding description: In this study, a comparison of 4 groups is considered that the participants in each group are not aware of the other groups and the place of the treatment they receive in the study (is it intervention or control?!).
The therapists who provide interventions are not aware of the main purpose of the study and the existence of four groups with different interventions.
Data analysis is performed by a person who has no contact with the participants, assessors and therapists.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Autism spectrum disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1:  twelve sessions of tDCS with electrode size 25 CM2 and 1 mA intensity in the left dorsolateral prefrontal cortex region (F3), which is determined according to the international classification system 10-20, for 20 minutes every week for 3 weeks (Four sessions per week) will provide; the reference electrode is placed on F4. Thirty seconds after starting current stimulation gradually reaches 1 mA and the final 30 seconds of current stimulation gradually decreases from 1 mA to zero. Intervention 2: Intervention group 2: tDCS with computerized cognitive rehabilitation- tDCS is described in the first intervention. When receiving tDCS, the child will simultaneously perform computerized tasks for 12 sessions of 20 minutes. These tasks are in the form of computerized games to strengthen working memory, attention and concentration, problem solving, planning, inhibition and other executive function skills. Intervention 3: Intervention group 3: tDCS with occupation-based cognitive rehabilitation-  tDCS is described in the first intervention. occupational cognitive rehabilitation in this study included 12 sessions of cognitive rehabilitation, two sessions per week, each session lasting 60 minutes; The first 30 minutes of each occupational cognitive rehabilitation program session will include meaningful and purposeful activities and games to improve executive functions, and the second 30 minutes of these sessions will focus on teaching the occupations that each child's parents determine  in interviewing the Canadian Occupational Performance Measure (COPM) and prioritize the child's problems in doing daily activities by stating their perceptions about child's performance and their satisfaction. Intervention 4: Control group: traditional cognitive training interventions- intervention through training strengthens the executive function components such as working memory, attention and concentration, problem solving, planning, and inhibition using educational equipment and pen and paper tasks. Children in this group will receive 12 training sessions for 6 weeks (two sessions per week), 1 hour per session.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is If It means SPSS data sheet, no at the moment; because we decide to publish several reports that the time period will be long and unpredictable.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Samaneh Karamali Esmaili</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Occupational therapy, School of Rehabilitation, Madadkaran alley, Shah-Nazari Street, Mirdamad Boulevard, Tehran,</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 7124</telephone>
        <email>samauneh.esmaeili@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Mehdi Alizadeh Zarei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Occupational Therapy, School of Rehabilitation, Madadkaran Alley, Shah-Nazari Street, Mirdamad Boulevard, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 7124</telephone>
        <email>mehdii.alizadeh@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Children aged 8-14 years with a diagnosis of level 1 autism spectrum disorder based on the diagnosis of a child psychiatrist and assessment by the GARS
If receive medication, at least two weeks have been passed since the start of the drug</inclusion_criteria>
      <agemin>8 years</agemin>
      <agemax>14 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>comorbid neurological disorder
receiving the tDCS during the previous year</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F84.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Autistic disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1:  twelve sessions of tDCS with electrode size 25 CM2 and 1 mA intensity in the left dorsolateral prefrontal cortex region (F3), which is determined according to the international classification system 10-20, for 20 minutes every week for 3 weeks (Four sessions per week) will provide; the reference electrode is placed on F4. Thirty seconds after starting current stimulation gradually reaches 1 mA and the final 30 seconds of current stimulation gradually decreases from 1 mA to zero.</i_keyword>
      <i_keyword>Intervention group 2: tDCS with computerized cognitive rehabilitation- tDCS is described in the first intervention. When receiving tDCS, the child will simultaneously perform computerized tasks for 12 sessions of 20 minutes. These tasks are in the form of computerized games to strengthen working memory, attention and concentration, problem solving, planning, inhibition and other executive function skills.</i_keyword>
      <i_keyword>Intervention group 3: tDCS with occupation-based cognitive rehabilitation-  tDCS is described in the first intervention. occupational cognitive rehabilitation in this study included 12 sessions of cognitive rehabilitation, two sessions per week, each session lasting 60 minutes; The first 30 minutes of each occupational cognitive rehabilitation program session will include meaningful and purposeful activities and games to improve executive functions, and the second 30 minutes of these sessions will focus on teaching the occupations that each child's parents determine  in interviewing the Canadian Occupational Performance Measure (COPM) and prioritize the child's problems in doing daily activities by stating their perceptions about child's performance and their satisfaction.</i_keyword>
      <i_keyword>Control group: traditional cognitive training interventions- intervention through training strengthens the executive function components such as working memory, attention and concentration, problem solving, planning, and inhibition using educational equipment and pen and paper tasks. Children in this group will receive 12 training sessions for 6 weeks (two sessions per week), 1 hour per session.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Executive function. Timepoint: before, after, and 1 month after the intervention (follow-up). Method of measurement: Behavior Rating Inventory of Executive Function (BRIEF)- Wisconsin Card Sorting Test (WCST)- Tower of London (ToL)- Stroop test.</prim_outcome>
      <prim_outcome>Occupational performance. Timepoint: before, after, and 1 month after the intervention (follow-up). Method of measurement: Canadian Occupational Performance Measure (COPM).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-04-07</approval_date>
        <contact_name>Iran University of Medical Sciences</contact_name>
        <contact_address>Shahid hemmat highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
